Pieris Pharmaceuticals Inc. News
Arbutus Higher After Report of Progress With Hepatitis B Drug
Data support continued evaluation of AB-729 'as the cornerstone of combination treatment' for Hepatitis B,' Arbutus Biopharma said.
Pieris Jumps on Grant for Drug to Treat Lung Scarring From COVID
Pieris received a grant of $17 million from the Bavarian Ministry of Economic Affairs for a drug to treat lung scarring in COVID sufferers.
Pieris Pharma Soars on Alliance With Roche's Genentech
Pieris Pharma shares soar as the biotech enters a drug-development agreement with Roche's Genentech.
Pieris Pharma Wavers After $13M Seagen Equity Investment
Pieris and Seagen have amended an ongoing collaboration which will have the latter give the former $13 million in an equity investment as the two work together to study a gastric cancer drug.
Centene, Square, NutriSystem: 'Mad Money' Lightning Round
A roundup of stocks callers asked Jim Cramer about on Mad Money.
How High Can This Market Go: Cramer's 'Mad Money' Recap (Friday 10/13/17)
Netflix is set to kick off a week of earnings reports that will go a long way to answering whether this market can keep going higher, according to Jim Cramer.
Analysts' Actions -- Fluor, L Brands, NetApp and More
Here are Wednesday's top research calls, including downgrades of Fluor and L Brands
The Arena Group Q2 Gross Profit Nearly Doubles; Revenue Up 87%
The Arena Group, publisher of Sports Illustrated, TheStreet, Parade and more, reported that Q2 gross profit, revenue and digital-ad revenue jumped.
Will JetBlue Take Away the One Thing People Like About Spirit?
The takeover of the budget airline raises a key question for consumers.
Micron and Nvidia: Buy or Sell After Bearish Updates?
Nvidia provided negative news on Monday and Micron followed up with more on Tuesday. Here's the trade.